ImmuPharma PLC
  • Announcements
  • About Us
    • About Us
    • Our Team
    • Board of Directors
  • Our Science
    • Our Science
    • ImmuPharma Biotech
    • Key Clinical Investigators
  • Pipeline
    • Pipeline
    • Autoimmunity & Inflammation
    • Anti-Infectives
  • Partnerships & Collaborations
  • Investors
    • Investors
    • AIM Rule 26 Information
    • Regulatory News
    • Corporate Governance
    • Board of Directors
    • Annual Reports
    • Analyst Research
    • Interviews
    • Professional advisers
    • Email Alerts
  • Contact
Archives
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
June 26, 2019

Subscription to raise £2.66 million

Read More
June 04, 2019

Notice of AGM and posting of Report & Accounts

Read More
May 24, 2019

FINAL RESULTS ANNOUNCEMENT for the twelve months ended 31 December 2018

Read More
May 07, 2019

Corporate Update

Read More
April 01, 2019

Update on Nucant cancer programme

Read More
March 14, 2019

IMM March 2019 Corporate Update

Read More
February 26, 2019

Technology review published in Nature Communications

Read More
  • 1
  • 2
  • Keep up-to-date with email alerts

  • @immupharma

Aim Rule 26 Contact informationDisclaimerPrivacy PolicySite map

© ImmuPharma PLC 2005-2022 | All rights reserved